Related Experiment Video
Updated: May 22, 2026
05:34
Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
Systemic inflammation and comorbidities in chronic obstructive pulmonary disease
1Institut del Tòrax, Hospital Clínic, Villarroel 170, Escala 3, Planta 5, 08036 Barcelona, Spain. alvar.agusti@clinic.ub.es
Proceedings of the American Thoracic Society
|May 3, 2012
Summary
Systemic inflammation
Area of Science:
- Pulmonary Medicine
- Inflammation Research
- Oncology
Background:
- Chronic Obstructive Pulmonary Disease (COPD) is frequently associated with comorbidities.
- Systemic inflammation plays a role in COPD pathogenesis and progression.
- The interplay between systemic inflammation, comorbidities, and lung cancer in COPD requires further elucidation.
Purpose of the Study:
- To review the prevalence and clinical impact of comorbidities in COPD patients.
- To summarize current knowledge on systemic inflammation in COPD, including its definition, prevalence, consequences, and treatment.
- To explore the relationship between systemic inflammation and lung cancer risk in COPD.
Main Methods:
- Literature review and synthesis of existing research.
- Analysis of epidemiological data on COPD comorbidities.
- Review of studies investigating systemic inflammation markers and their association with COPD and lung cancer.
Main Results:
- Comorbidities are highly prevalent in COPD, significantly impacting clinical outcomes.
- Systemic inflammation is a recognized feature of COPD, contributing to disease severity and extrapulmonary manifestations.
- Evidence suggests a link between systemic inflammation and an increased risk of lung cancer in COPD patients.
Conclusions:
- Understanding the complex relationship between systemic inflammation, comorbidities, and lung cancer is crucial for comprehensive COPD management.
- Targeting systemic inflammation may offer therapeutic potential for reducing comorbidity burden and lung cancer risk in COPD.
- Further research is needed to clarify the causal pathways and develop targeted interventions.
Related Concept Videos
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...